Inge Wijnbergen

Safety and performance of the drug-eluting absorbable metal scaffold (DREAMS) in patients with de-novo coronary lesions: 12 month results of the prospective, multicentre, first-in-man BIOSOLVE-I trial

Raimund Erbel, Neil Weissman, Francesco Prati, 2013, The Lancet.